{
  "id": "a83a0c04092e74e8",
  "title": "Primary Endpoint Successfully Achieved in Lexaria Phase 1b Study GLP - 1 - H24 - 4",
  "description": "20251224T103000Z",
  "content": "",
  "source": "tennesseedaily.com",
  "source_url": "http://www.tennesseedaily.com/news/278770959/primary-endpoint-successfully-achieved-in-lexaria-phase-1b-study-glp-1-h24-4",
  "published_at": "20251224T103000Z",
  "fetched_at": "2025-12-25T00:22:49.565695+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.tennesseedaily.com/news/278770959/primary-endpoint-successfully-achieved-in-lexaria-phase-1b-study-glp-1-h24-4",
    "url_mobile": "",
    "title": "Primary Endpoint Successfully Achieved in Lexaria Phase 1b Study GLP - 1 - H24 - 4",
    "seendate": "20251224T103000Z",
    "socialimage": "",
    "domain": "tennesseedaily.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}